President Cyril Ramaphosa has made commitments for equitable access to the Covid-19 vaccine for South Africa through Covax, the global effort to coordinate production and distribution in the second quarter of next year. But to date we have not seen any details around bi-laterals with pharmaceutical companies and a national deployment plan in administering the roll-out.
This is despite the World Health Organisation’s guideline for a National Deployment and Vaccine Plan, which is ideally to ensure country readiness for Covid-19 vaccine roll out and yet South Africa continues to hide and not consult on this strategy.